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Introduction
In the fi eld of food chain safety, decision makers have a 
responsibility to promote the health of plants, animals and 
humans, and to protect the national and international econ-
omy. For that purpose, decisions should be made on diff erent 
intervention opportunities, based on the risk analysis frame-
work defi ned fi rst by FAO/WHO (2006). However, during 
this process, not only the risk (or burden) of the diseases, but 
intervention feasibility, eff ectiveness and cost, equity and 
ethical considerations also play increasingly important roles. 
In this respect, food safety risk analysis and health technol-
ogy assessment (HTA) in healthcare system development 
are analogue paradigms. The aim of this paper is to identify 
those elements of HTA methodology suitable for quantitative 
decision support in food safety risk analysis.
The diff erent methodologies for ranking the risks related 
to feed/food safety and nutritional hazards, on the basis of 
their anticipated human health impact, assessed by Van der 
Fels-Klerx et al. (2015) show a large variability in applica-
tion, emphasising that each tool has its optimal purpose of 
use. The decision making process in the food chain safety 
domain uses many quantitative tools, especially during risk 
assessment, however the decision making as a whole is still 
mostly a qualitative process that applies ad hoc weights to 
all aspects considered. Interestingly, the practice of multi-
aspect HTA decision making has changed a lot in the last 
two decades, resulting in the establishment and widespread 
use of sophisticated quantitative approaches to support and 
justify evidence-based decisions (Bodrogi and Kaló, 2010).
In this paper, we overview the current status of food-
borne pathogen ranking, explain the role of full economic 
evaluation and multi-criteria decision making in HTA with 
implications for food safety risk management, and discuss 
the opportunities and barriers of risk-benefi t evaluations in 
food safety decisions.
Pathogen burden ranking for food 
safety risk prioritisation: from DALY 
to QALY
The burden of domestic foodborne diseases in the United 
States (U.S.) due to various pathogens has been systemati-
cally re-assessed by Scallan et al. (2011a, 2011b), providing 
new point estimates with 90 per cent credible intervals on 
the number of illness episodes, hospitalisations and deaths 
caused by 31 main pathogens (including bacteria, viruses 
and parasites). They found that no specifi c pathogens were 
recognised in the majority of illnesses, hospitalisations and 
deaths due to U.S. domestic foodborne diseases. Considering 
the cases with known pathogens, most illnesses were caused 
by norovirus (58 per cent), while non-typhoidal Salmonella 
species were the leading cause of hospitalisation (35 per cent) 
and deaths (28 per cent). Ranking the pathogens according 
to their disease burden strongly depends on how the disease 
burden is measured. For example, Listeria monocytogenes 
is responsible only for a negligible number of annual illness 
episodes as compared with other pathogens, but is ranked 
among the top three causes of domestic foodborne disease-
related deaths. The annual health burden of domestically 
acquired foodborne illnesses in the U.S. (incidence of ill-
nesses, hospitalisations and deaths) was estimated by Mead 
et al. (1999) and Scallan et al. (2011a, 2011b). Note that the 
diff erent methods do not allow trend analyses between the 
PITTER János G.*, JÓŹWIAK Ákos**, MARTOS Éva***, KALÓ Zoltán*‡ and VOKÓ Zoltán*‡
Next steps to evidence-based food safety risk analysis: opportu-
nities for health technology assessment methodology implemen-
tation
Food safety risk analysis and health technology assessment (HTA) are two diff erent paradigms sharing multiple common fea-
tures. Decision makers in both fi elds have the responsibility to promote the health of society deciding on intervention opportuni-
ties based on disease burden, intervention feasibility, eff ectiveness and cost, equity and ethical considerations. The evolution 
of HTA in the last two decades has resulted in the establishment and widespread use of quantitative tools to support and justify 
evidence-based decisions. In contrast, decision making in the food safety domain is still a qualitative process rendering ad hoc 
weights to all aspects considered. This review evaluates whether HTA methodology is suitable for quantitative decision support 
in food safety risk analysis. We conclude that cost-utility analysis (CUA) could better serve the priority settings in food safety 
risk management than the currently (rarely) applied cost-benefi t analysis (CBA), considering either broad resource alloca-
tion or specifi c safety measure decisions. Development of multi-criteria decision analysis tools could help the introduction of 
consistent and explicit weighting among cost and health impacts, equity and all other relevant aspects. Cost-minimisation and 
cost-eff ectiveness analyses would be relevant for ‘threshold’ and ‘as low as reasonably achievable’ approaches to single food 
safety risk assessments, respectively. Assuming a future widespread use of HTA methodology in the food safety paradigm, a 
vision of integrated healthcare, food safety and nutritional policy emerges, with the re-evaluation of budgets and resources of 
these large systems in a rational and socially acceptable way.
Keywords: foodborne disease, cost-utility analysis, MCDA, health technology assessment, risk analysis, priority setting
* Syreon Research Institute, 1142 Budapest, Mexikói út 65/A, Hungary. Corresponding author: janos.pitter@syreon.eu
** Nemzeti Élelmiszerlánc-biztonsági Hivatal, Budapest, Hungary.
*** Országos Élelmezés- és Táplálkozástudományi Intézet, Budapest, Hungary.
‡ Eötvös Loránd Egyetem, Budapest, Hungary.
Pitter János G., Jóźwiak Ákos, Martos Éva, Kaló Zoltán and Vokó Zoltán
156
Mead and the Scallan studies.
Estimation of the overall disease burden of particular 
pathogens requires an integrated approach with appropriate 
weights for mild cases, hospitalisations and acute deaths. 
Moreover, disease burden calculations should also consider 
the potential long-term consequences, such as increased risk 
of Guillain-Barré syndrome after Campylobacter infections, 
haemolytic uremic syndrome with or without end-stage renal 
disease after E. coli O157 and Shiga toxin producing E. coli 
(STEC) non-O157 infections, or newborn complications 
after listeriosis and toxoplasmosis (Hoff mann et al., 2012; 
Scharff , 2012; Batz et al., 2014). The new incidence esti-
mates published by Scallan et al. (2011b) elicited a series of 
updated estimations on overall domestic foodborne disease 
burden due to particular pathogens in the U.S. Scharff  (2012) 
calculated the total cost of illness as the sum of costs of phy-
sician care, hospitalisation, pharmaceuticals, cost of produc-
tivity loss and the value of statistical life for fatal cases, also 
considering long-term consequences. Decreased quality of 
life as captured by quality adjusted life years (QALY) loss 
(health utility decrements of 0.492 during hospitalisation 
and 0.311 during illness episode) was also monetised and 
included in the enhanced cost of illness model. Hoff mann et 
al. (2012) integrated the new incidence estimates of Scallan 
et al. (2011b) with a thorough literature review and recon-
sidered the disease outcome trees (symptoms, severity, dura-
tion and likelihood of health outcomes) for 14 key pathogens 
in the U.S. Symptom defi nitions were scored along the fi ve 
domains of EQ-5D and new, health state-specifi c utility dec-
rement data were generated and reviewed by clinical experts 
of foodborne diseases. Updated disease outcome trees were 
then used to estimate the total cost of illness (sum of medi-
cal costs, productivity loss and value of premature mortal-
ity) and total QALY loss (including decreased life quality 
and disease related mortality). The cost of illness and QALY 
loss are not additive in this study because both capture the 
burden of premature mortality. In a recent paper, the same 
team published new estimates on QALY loss for the same 
14 key pathogens, with slightly reduced QALY losses in 
Cryptosporidium and Shiga toxin producing non-O157 E. 
coli infections (Batz et al., 2014).
Ranking of foodborne pathogens by their disease bur-
den is part of a new risk-ranking model of the Food Safety 
Research Consortium, with the intention of attributing path-
ogen-specifi c disease burden and costs to categories of food 
vehicles, based on outbreak data and expert judgment (Batz 
et al., 2004; Hoff mann et al., 2007). The ultimate goal of this 
work is to support priority setting and resource allocation for 
food safety, in two contexts (Batz et al., 2005). The fi rst con-
text (‘Purpose 1’ or ‘High level/Strategic priority setting’) 
is broad resource allocation, i.e. which of many possible 
pathogens or pathogen-food pairs pose the greatest concern 
to public health and therefore deserve priority attention for 
intervention or further analysis. This level of prioritisation 
intends to support programmes or agencies during strategic 
planning, developing annual work plans or annual budget 
requests. The second context (‘Purpose 2’ or ‘Decision on 
risk management options’) is to support the choice of specifi c 
risk management actions and strategies with respect to a par-
ticular hazard. This latter context may also utilise the results 
of foodborne pathogen attribution to key food sources, by 
focusing the attention to the critical elements and steps in the 
food supply chain.
In parallel with the work in the U.S., the estimation of 
foodborne disease burden is the subject of intensive research 
worldwide with the intention of ranking foodborne patho-
gens and food pathogen-food pairs to guide foodborne 
disease-related policy decisions. The systematic estimation 
of the numbers of illnesses, hospitalisations and deaths for 
30 foodborne pathogens in Canada have been recently pub-
lished (Thomas et al., 2013), and the attribution of selected 
pathogens to food sources was also approached (Davidson 
et al., 2011). The World Health Organization continues its 
programme to quantify the global burden of foodborne dis-
eases in disability-adjusted life years (DALY), recently ini-
tiating four pilot country studies in Albania, Japan, Uganda 
and Thailand (Kuchenmüller et al., 2013). Country-specifi c 
research papers on disease burden of a single (Tariq et al., 
2011; Fürst et al., 2012; Verhoef et al., 2013) or a couple 
of specifi c foodborne pathogens (Lindqvist et al., 2001; Van 
den Brandhof et al., 2004; Kemmeren et al., 2006; Haagsma 
et al., 2009; Lake et al., 2010; Ruzante et al., 2010; Havelaar 
et al., 2012) also report on the health burden of foodborne 
diseases as captured in DALY metrics. An exception in this 
respect is the work of Shin et al. (2010), quantifying the 
Korean health burden of foodborne pathogens as QALY loss 
estimates. Unfortunately, this group failed to report patho-
gen-specifi c burden of disease data.
Although both DALY and QALY are population health 
metrics describing morbidity and mortality simultaneously 
in a single number, they were developed with diff erent inten-
tions and are not interchangeable. DALY was developed 
to describe health at population level, without the aim of 
responsiveness to slight health changes at individual level. 
In contrast, the primary aim of developing the QALY meth-
odology was to support the evaluation of medical interven-
tions (Gold et al., 2002). Since QALY became the dominant, 
almost exclusively used, health denominator in health tech-
nology assessment, the authors argue that cost-utility analy-
ses in food safety risk analysis shall also adopt QALY for the 
standard quantifi cation of the health impacts of food safety 
policies. Applying QALY as a universal health currency 
could facilitate the comparison of eff ectiveness and cost-
eff ectiveness of health and food safety policies, describing 
their health eff ects in a common language.
Full economic evaluation in HTA, 
with implications for food safety risk 
management
Once the expected health benefi ts of a planned new tech-
nology are quantifi ed, the next step is to compare the health 
benefi ts with the economic impacts of the intervention. In 
HTA, the standard approach is a full economic evaluation 
which has two criteria: (a) the selection of a policy-relevant 
comparator (which can be an already-applied intervention or 
the lack of any intervention (watchful waiting), depending 
on the current state of the art); and (b) both the costs and 
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health gain must be examined. In other words, full economic 
evaluations compare at least two alternative technologies by 
examining both economic impacts and health consequences 
(Drummond et al., 1997). There is abundant literature on the 
full economic evaluations of health technologies. In contrast, 
published full economic analyses on food safety risk man-
agement (or risk analysis in the broader sense) measures are 
sparse. However, recent food safety publications tend to pay 
more and more attention to health quality beyond costs and 
mortality, providing important input and allowing for future 
full economic analyses. The Scharff  (2012) study mon-
etised the hospitalisation- and illness-related health losses 
in its enhanced cost of illness model. The extensive work 
described in Hoff mann et al. (2012) and Batz et al. (2014) 
opened the door for full economic analyses of risk manage-
ment measures against 14 investigated foodborne patho-
gens, providing detailed disease outcome trees and QALY 
loss estimates. What is still missing is the identifi cation of 
appropriate alternative intervention measures for compari-
son, with data on their expected eff ect on disease incidence, 
and information how the disease outcome trees would be 
changed by these interventions.
Health and cost data for a full economic evaluation can be 
generated in three parallel ways in HTA. Randomised inter-
ventional studies may collect data with high internal validity, 
although these studies are typically limited in size and dura-
tion, and their protocol may limit meaningful economic data 
collection (e.g. reduction in the number of outpatient visits 
cannot be evaluated in a study with protocol-specifi ed regu-
lar investigator visits). Naturalistic studies provide informa-
tion on a larger and less standardised population, with higher 
external validity. However, health outcomes may be subject 
to confounding in these studies due to the lack of randomisa-
tion, and conducting naturalistic studies for new health care 
technologies can hardly be implemented before approval on 
their market authorisation, pricing and reimbursement. A 
third line of evidence generation in HTA is economic model-
ling, with decision tree, Markov and discrete event simula-
tion models as the most frequently applied techniques. In 
economic models, clinical data from randomised clinical 
trials and naturalistic studies or any other data sources are 
synthesised, enabling the model to project intermediate 
clinical and economic results to longer time horizons, and 
thus estimate the potential long-term value of the assessed 
technology. For comparison, multiple relevant data sources 
are available for food safety risk analysis. Short-term data 
of high scientifi c quality and internal consistency can be 
gathered, for example in statistically planned and evaluated 
experiments in the laboratory or in fi eldwork (an analogue of 
randomised controlled clinical trials in HTA). Naturalistic, 
large-scale uncontrolled data are also available, for exam-
ple from the analysis of the practices of diff erent countries. 
There is also a need for risk management decisions on long-
term and expensive programmes ex ante, without available 
data on their real-world eff ectiveness and cost-eff ectiveness 
– justifying the use of economic modelling in the evalua-
tion of the planned measures as part of the food safety risk 
analysis process. The estimation of foodborne disease bur-
den between 2020 and 2060 in the Netherlands (Bouwknegt 
et al., 2013), or the microsimulation of households behav-
iour to assess the impact of food safety policies on society 
(Stefani, 2008) are mentioned here as food safety modelling 
examples.
Full economic analyses in HTA are classifi ed to cost-
minimisation, cost-eff ectiveness, cost-utility and cost-ben-
efi t analyses, according to the measurement units of health 
gain. The relevance of these analyses in the food safety risk 
analysis process is summarised in Table 1.
Although cost-benefi t analyses, which can aggregate and 
thus compare in monetary values any kind of food safety 
measures with each other or with non-health related invest-
ment options, have the widest scope, the validity, reliability 
and acceptance of converting health benefi ts into monetary 
values are low (Cowen, 1998; Bodrogi and Kaló, 2010). 
Therefore, cost-utility analyses should be preferred over 
cost-benefi t analyses whenever appropriate. Such analyses 
can aggregate and thus compare any kind of food safety 
measures, including measures against diff erent risks, or 
multiple risks in a comparative risk approach (for example 
(FAO/WHO, 2006), the possible loss of nutritional benefi ts 
if people eat less fi sh in order to avoid methylmercury; or 
the possible increase in cancer risks where chlorinated water 
is used to minimise pathogens in food during processing). 
Cost-utility analyses do not monetise health losses and ben-
efi ts, but convert them into QALY changes – circumventing 
the uncertainties and ethical disputes about the monetary 
value of health. Another advantage of cost-utility analy-
sis is that it emphasises the relevance of a thorough health 
impact assessment. Accordingly, cost-utility analysis would 
be the preferred method of economic assessment for broad 
Table 1: Types of full economic analyses in health technology assessment, with their proposed applicability in food safety risk analysis.
Type of analysis Unit of health gain Applicability in HTA* Applicability in food safety risk analysis
Cost-minimisation Not specifi ed (equal health gain)
Comparison of medical procedures with equal 
health gain.
Compare two measures both achieving the ALOP, 
or the respective FSO in a threshold approach.
Cost-eff ectiveness Natural units
Comparison of medical procedures with 
non-equal health gain measurable in the same 
health dimension.
Compare two measures against the same risk in 
an ALARA approach.
Cost-utility QALY Comparison of any medical procedures.
Compare any kind of food safety measures and/
or healthcare interventions (prioritisation among 
health-related investments).
Cost-benefi t Monetary value Comparison of any medical and non-medical procedures and investment options.
Prioritisation of health-related versus not health-
related investments.
* Source of information: Bodrogi and Kaló (2010)
Key: ALARA: as low as reasonably achievable; ALOP: appropriate level of protection; FSO: food safety objective; QALY: quality adjusted life years
Note: for all four types of analysis, the unit of costs is ‘monetary value’
Source: own composition
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resource allocation (‘Purpose 1’ prioritisation in Batz et al., 
2005); whereas the selection of an optimal measure against 
a specifi c risk could rely on cost-utility, cost-eff ectiveness or 
cost-minimisation analyses, depending on the determination 
of the Appropriate Level of Protection and the occurrence of 
multiple risks or health consequences.
Systematic application of the above discussed full eco-
nomic evaluations could contribute to the development of 
more rational and transparent food safety systems, with 
improved allocation eff ectiveness.
Multi-aspect decisions in food safety 
risk management and in HTA
Risk ranking tools, like the ranking of hazard-food com-
binations in a national context, are acknowledged scientifi c 
approaches in the framework of food safety risk analysis 
(FAO/WHO, 2006). However, the decision on a particular 
measure against a specifi c risk does not rely solely on the 
magnitude of the risk. It also needs to assess carefully the 
feasibility, eff ectiveness and cost of potential interventions, 
as well as their expected public health benefi ts (Batz et al., 
2005; FAO/WHO, 2006). These considerations are also valid 
for broad resource allocation decisions and the planning of 
food safety programmes (Hoff mann, 2010; Hoff mann et al., 
2012; Scharff , 2012). Assessment of health burden, inter-
vention feasibility, eff ectiveness and costs allows the risk 
managers to select risk management measures which reach 
their targets, are cost-eff ective and are not over-restrictive. 
Risk managers shall also consider stakeholder equity, ethical 
considerations and potential consequences on other risks (for 
example, decreases in the availability or nutritional quality 
of foods, or increasing burden of currently well-controlled 
pathogens upon redistribution of food safety resources to key 
pathogens). Although cost-benefi t analysis is a mandatory 
element of food safety policy decisions in some countries, 
it typically does not cover all relevant aspects, e.g. qual-
ity of life (Ragona and Mazzocchi, 2008) and is believed 
to have frustrating uncertainty in its parameter estimates 
(Irz, 2008). Hence, balancing between health burden, costs 
and expected benefi ts of intervention measures, consider-
ing diff erent stakeholder perspectives, and dealing with the 
expected impact on food trade, trust of society in the food 
chain, and eff ects on economy is essentially a qualitative 
process. Accordingly, the selection of the implemented risk 
management options is fundamentally a political and social 
decision at present (FAO/WHO, 2006).
As a response to this challenge in health technology 
assessment, multi-criteria decision analysis (MCDA) tools 
have been developed to cover all important aspects of deci-
sion making with standardised weights. The quantitative 
result of a full economic analysis is typically an important 
component of the multi-criteria decision process, but equity, 
ethical and socio-cultural aspects are also covered with rel-
evant weights, in an objective and transparent manner.
Developing appropriate MCDA tools to support evi-
dence-based, objective risk management decisions, incorpo-
rating full economic analyses of the considered measures, is 
a future opportunity for international and national food safety 
policies. Previous steps in this direction include a multi-
criteria decision support tool with integrated presentation of 
cost-benefi t analysis and other criteria for food safety prior-
ity setting focusing on food-pathogen pairs (Caswell, 2008). 
Another example is the institution of Impact Assessment 
in the UK, which combines the fi ndings of a full economic 
analysis with multiple other aspects of assessment (Irz, 2008) 
without the quantitative integration of all fi ndings.
Opportunities and barriers to using 
HTA methodology in food safety risk 
management decisions
Frequently cited arguments against risk-benefi t evalu-
ations in food safety risk management decision processes 
include the issues of uncertainty in model parameters (Irz, 
2008), unpredictable eff ects of risk management measures 
on stakeholders’ behaviour (FAO/WHO, 2006; Ragona and 
Mazzocchi, 2008), and the technical and theoretical diffi  -
culties with calculation and monetisation of health benefi ts 
(Cowen, 1998; Irz, 2008).
Uncertainty is an inherent part of all ex ante impact 
analyses and is appropriately managed in the health tech-
nology assessment process by deterministic or probabilis-
tic sensitivity analyses – which are quantitative tools also 
available for food safety risk management. It is claimed that 
the level of uncertainty is especially high in food safety risk 
analysis. For example, the lack of long-term human data on 
the biological eff ect of reduced levels of chemical contami-
nants does not allow reasonable assumptions on the expected 
health impact (Irz, 2008). Risk management measure con-
cepts without reasonable assumptions on their eff ectiveness 
may be premature to implement (unless a precautionary 
approach is considered). Assumptions with a weak basis call 
for additional risk assessment exercises, sensitivity analyses 
in the full economic evaluation, representation of uncertainty 
in the decision process (preferably via an MCDA tool) and 
regular monitoring during practical implementation to adjust 
the assumptions and the full economic evaluation to the real-
world experience.
Unpredictable eff ects of risk management measures on 
stakeholders behaviour is not considered to be a valid argu-
ment against risk-benefi t analyses, because communication 
between all involved stakeholders is at the heart of risk anal-
ysis, with equally emphasised importance of risk manage-
ment, risk assessment and good risk communication (FAO/
WHO, 2006).
Cost-benefi t analyses have their limitations, but are prob-
ably the most appropriate currently-used approach to the 
assessment of food safety interventions (Irz, 2008). A recent 
U.S. News Opinion Economic Intelligence comment also 
emphasises the distinguished thesis that more funding and 
more regulations do not automatically result in better health 
and food safety, and calls for well-done, peer-reviewed cost-
benefi t analyses of future regulations, as well as for retro-
spective review of similar regulations done in the past to 
show their eff ectiveness (Williams, 2014).
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Although QALY are used routinely in health technology 
assessment, the integrated evaluation of environmental-
related health risks traditionally uses alternative approaches 
(e.g. willingness to pay, or cost of disease (Hammitt, 2002; 
Scallan et al., 2011b; Hoff mann et al., 2012). The health bur-
den of foodborne diseases is typically quantifi ed in DALY, 
as summarised in the fi rst section of this paper. Recently-
published work in the U.S. (Hoff mann et al., 2012; Scharff , 
2012; Batz et al., 2014) represent a breakthrough in this 
respect, providing updated, scientifi cally-sound disease out-
come trees with disease state-specifi c estimates of QALY 
losses for 14 key foodborne pathogens. These pieces of 
information open the door for cost-utility analyses to enter 
the fi eld of food safety risk management, avoiding the need 
to monetise the calculated health losses. The systematic use 
of cost-utility analyses is encouraged both for broad resource 
allocation and for evaluation of alternative measures in food 
safety risk management.
Full economic analyses followed by an MCDA tool pro-
vide an established, objective and transparent methodology 
for multi-aspect health technology and policy assessment. 
The application of the same methodology is an opportunity 
for the development of evidence-based, transparent food 
safety risk management. One could object to this approach 
in that it would further increase the information burden and 
unnecessary bureaucracy. However, even without the uptake 
of the proposed quantitative methodology, most probably the 
same pieces of information are considered by risk manag-
ers, but on an ad hoc basis (Caswell, 2008). The proposed 
integration of HTA methodology into the food safety risk 
analysis process is shown in Figure 1.
Conclusion: a vision of an inte-
grated, evidence-based health and 
food policy
Sharing the established methodological tools of health 
technology assessment with food safety risk analysis would 
be a reasonable achievement. Moreover, the shared meth-
odology would pave the way to the integration of health 
and food policies. According to this vision, cost-utility 
analyses of health and food policies would support the broad 
resource allocation between these policies, investing public 
expenditure in these fi elds proportionally to their expected 
health benefi ts. And within these policies, the selection of 
technologies, interventions and any policy measures would 
be supported by full economic analyses without health gain 
monetisation (i.e. cost-utility, cost-eff ectiveness and cost-
minimisation analyses), together with the country-specifi c 
development of MCDA tools to deal explicitly and trans-
parently with all relevant aspects of policy decisions. This 
would lead to systematic and evidence based food safety 
decision process along the whole risk analysis framework, 
with increased transparency, ensuring better and more justifi -
able decisions with higher societal values and gains.
Setting up priorities between diseases caused by specifi c 
foodborne pathogens is clearly a necessary and straightfor-
ward approach. However, it must be remembered that most 
domestic foodborne pathogen related diseases, hospitalisa-
tions and deaths have consistently failed to be linked to a 
specifi c pathogen in the U.S. (Mead et al., 1999; Scallan et 
al., 2011a). Moreover, foodborne pathogens are by far not the 
only causes of foodborne diseases: food safety risk analysis 
activities must face also the risks due to food additives and 
contaminants (e.g. mercury and dioxins, natural toxins such 
as afl atoxins, residues of pesticides and veterinary drugs) as 
well as physical risks (Mead et al., 1999; FAO/WHO, 2006). 
Accordingly, the issue of broad resource allocation in food 
safety risk management shall not be restricted to the prioriti-
sation among known foodborne pathogens.
In a wider context, let us consider the borders between 
food safety and nutritional policy. Beyond foodborne infec-
tions and toxicity, the qualitative and quantitative character-
istics of food consumption also have tremendous impact on 
life quality and expectancy. Excess intake of calories, satu-
rated and trans fats, free sugar and sodium, as well as low 
consumption of vegetables and fruits contribute signifi cantly 
to rising rates of chronic diseases including hypertension, 
heart disease, stroke, diabetes and obesity (Nolte and McKee, 
2008; DHHS, 2013). On the other hand, under-nutrition is 
an important burden in low income countries. Assuming 
an integrated food safety and nutritional policy, the overall 
ambition is not only to prevent foodborne infections and 
toxicity, but in a more global sense to promote health by 
any means targeting the proper consumption habits of safe 
food by society. In fact, food safety and nutrition policies 
are strongly interlinked at high-level decision making in the 
European Union at DG SANTE and in the European Food 
Safety Authority. In the U.S., the FDA Food Program has 
a dedicated sub-programme for better health through nutri-
tion and labelling strategies (DHHS, 2013). Further steps 
to this integration might include the cost-utility analysis of 
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Figure 1: Place of health technology assessment tools in the food 
safety risk analysis process.
CBA: cost-benefi t analysis; CEA: cost-eff ectiveness analysis; CMA: cost-minimisa-
tion analysis; CUA: cost-utility analysis; MCDA: multi-criteria decision analysis
Source: adapted from FAO/WHO (2006)
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resource allocation across these fi elds. Apparently, this is not 
the practice at present.
Healthcare, nutrition policy and food safety risk analy-
sis are closely interlinked by their health promoting aspect. 
Patients with acute foodborne infections may later be faced 
with chronic consequences, such as renal failure after STEC 
infection, Guillain-Barré syndrome after Campylobacter 
infection, or hepatocellular cancer due to afl atoxin con-
tamination in nuts. Patients with excess calorie intake have 
increased risk of type II diabetes, which is one of the largest 
burdens on current healthcare budgets in developed coun-
tries. Development of improved therapies should logically 
shape the prioritisation among nutritional risk factors. On 
the other hand, appropriate investments in food safety and 
nutritional policies may help to avoid signifi cant health loss 
and healthcare expenditures. Accordingly, food safety and 
nutritional policies and interventions form two particular 
‘classes’ of health technologies.
Consumption of specifi c nutrients or vitamins is part of 
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